Skip to content
  • There are no suggestions because the search field is empty.

What is our iPRS™ for breast cancer test?

This test combines a person's genetic information with their personal and family history and clinical factors to provide a five-year and lifetime risk estimate for developing breast cancer for individuals who do not have single gene-driven hereditary breast cancer risk.

Who is the Breast Cancer iPRS™ test for?

This test is intended for individuals assigned female at birth, aged 18-84 years old. Individuals with a confirmed pathogenic variant in a breast cancer predisposition gene or with a personal history of breast cancer are not eligible for this test.